GlaxoSmithKline 73 Financial statements This section comprises the Directors statements, the independent auditors report on the Financial statements, the Financial statements consisting of the principal Financial statements and supporting notes, and additional financial data.
74 Directors statements of responsibility 75 Independent Auditors report Financial statements 76 Consolidated statement of profit and loss 76 Consolidated statement of total recognised gains and losses 78 Consolidated statement of cash ow 80 Consolidated balance sheet 80 Reconciliation of movements in equity shareholders funds 81 Company balance sheet 82 Notes to the financial statements 1.
New accounting policies and requirements 4.
Merger of Glaxo Wellcome and SmithKline Beecham 6.
Merger items, restructuring costs and divested businesses 8.
Joint ventures and associated undertakings 11.
Provisions for liabilities and charges 24.
Share capital and share premium account 28.
Financial instruments and related disclosures 33.
GlaxoSmithKline plc investment in subsidiary companies 37.
Reconciliation to US accounting principles 38.
Principal Group companies Financial record 142 Quarterly trend 148 Five year record
